Collegium Pharmaceutical Inc - COLL Quarterly Revenue Growth

Corporate company logo of Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical strictly adheres to ESG standards, monitoring raw materials and wastewater treatment. The business relies on stable demand from patients with chronic pain, which guarantees macro-resilience. Environmental initiatives focus on packaging recycling and drug disposal. The quarterly revenue growth trend clearly demonstrates income development, with this metric equal to 3.30.

COLL (Collegium Pharma) Revenue Change vs Previous Quarter history from 07/04/2022 to 11/20/2026

Summary analytical data breakdowns for Collegium Pharma (COLL)

- current quotes and average value forecast:
Initial company analysis:Collegium Pharmaceutical - COLL
Flagship merchandise of Collegium Pharmaceutical, Inc.

The business specifics of Collegium Pharmaceutical (COLL) are linked to regulatory pressure in the analgesics segment and legal risks regarding opioid litigation. By analyzing the pace of quarterly revenue growth, an investor assesses the percentage change in sales compared to the same period last year to confirm business resilience; however, a slowdown in this trend amid high share prices creates the risk of overpaying for the asset.